Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of remimazolam vs dexmedetomidine on bradycardia in lower limb orthopedic surgery under neuraxial block
KCT0007556Phase 4Not yet recruiting
- Sponsor
- Hana Pharm
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam, dexmedetomidine in postoperative pain, bradyarrhythmia, sponsored by Hana Pharm. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
remimazolamdexmedetomidine
03
Conditions
postoperative painbradyarrhythmia
Beyond the preview
Go deeper on KCT0007556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007556.